In today’s evolving regulatory landscape, Medical & Scientific Writing goes far beyond drafting documents. It’s about shaping a clear, strategic narrative that supports your development milestones and facilitates efficient approvals.
At Asphalion, our Medical Writing team partners with biotech and pharmaceutical companies to translate complex scientific data into high-quality, submission-ready documentation aligned with global regulatory expectations.
We regularly support the development of:
- Investigational Medicinal Product Dossiers (IMPD)
- Investigator’s Brochures (IB)
- Investigational New Drug applications (INDs)
- Paediatric Investigation Plans (PIPs)
- Orphan Drug Designation (ODD)
- Dossier preparation and adaptations for global submissions
- Regulatory responses to agencies
- Bibliographic research and scientific publications
With more than 25 years of regulatory expertise behind every document, we ensure clarity, consistency, compliance — and efficiency.
Because well-crafted documentation doesn’t just support your project. It strengthens your entire regulatory strategy.
Planning regulatory documentation for 2026? Let’s connect! [email protected]
